drugset / Trial / NCT00816790

Standard Vs Adjusted Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic Shock

NCT00816790 ↗

Phase 4 Terminated 20 enrolled Fraser Health
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to determine the feasibility of conducting a large scale randomized controlled trial comparing standard and renally adjusted dosage of antibiotics in the septic shock patients with acute renal dysfunction. We will use Piperacillin as the prototype antibiotic in our study.

Timeline

Start
2009-01
Primary completion
2011-05
Completion
2011-06

Outcome

Outcome not reported

Stopped: “Study stopped because of study personel movement to another institution.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Piperacillin/Tazobactam Unknown 2.25 g Intravenous
Subject Piperacillin/Tazobactam Unknown 3.375 g Intravenous
Subject Piperacillin/Tazobactam Unknown 4.5 g Intravenous